MedPath

Spontaneous Hemoperitoneum in Pregnancy (SHiP) and Endometriosis – Impact on Quality of Life and Illness Perceptio

Recruiting
Conditions
Endometriosis, SHiP, hemoperitoneum, pregnancy
Registration Number
NL-OMON21857
Lead Sponsor
VU University Medical Center Amsterdam
Brief Summary

ier MC, van Waesberghe JH, Maas JW et al. The relation between Spontaneous Hemoperitoneum in Pregnancy (SHiP) and endometriosis - data from a Nationwide Dutch consorted action. Poster presented at the Annual Meeting of the European Society of Human Reproduction and Embryology, 3-6 July 2016, Helsinki, Finland.

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
11
Inclusion Criteria

Eleven women with SHiP in their obstetrical history, who already gave written permission to include their case in our previous case-series, will be asked to participate in this trial.
Partners will be asked separately if they are willing to participate.

Exclusion Criteria

If women or their partners are unable or unwilling to give informed consent, they will be excluded from participation in this trial.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The aim of this study is to gain better insight in the psychological and functional recovery of women, and their partners, after SHIP.
Secondary Outcome Measures
NameTimeMethod
This study will further assess personality characteristics, illness perception, coping strategies and QOL of women, and their partners, after SHIP.
© Copyright 2025. All Rights Reserved by MedPath